Citius Oncology (CTOR) Times Interest Earned (2023 - 2026)
Citius Oncology's (CTOR) quarterly Times Interest Earned came in at -$4.16 in Q1 2026, up 98.31% year-on-year from -$2.1 in Q1 2025, and down 2533.13% on a QoQ basis from -$0.16 in Q4 2025.
Citius Oncology (CTOR) Times Interest Earned (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has 4 years of Times Interest Earned data on file, last reported at -$4.16 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 98.31% year-over-year to -$4.16 in Q1 2026; TTM through Mar 2026 was -$6.32, a 95.2% increase from a year earlier, with the FY2025 full-year figure at -$4.37, down 149.14% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$4.16, down from -$0.16 in the prior quarter.
- Over the last five years, Times Interest Earned for CTOR reached as high as -$0.11 in Q2 2025 and fell as low as -$246.03 in Q1 2025.
- Historically, Times Interest Earned has averaged -$61.78 across 4 years, with a median of -$9.01 in 2024.
- On a YoY basis, Times Interest Earned climbed as much as 99.93% in 2025 and fell as far as 5466.6% in 2025.
- Year by year, Times Interest Earned stood at -$149.93 in 2023, then surged by 90.92% to -$13.61 in 2024, then jumped by 98.84% to -$0.16 in 2025, then sank by 2533.13% to -$4.16 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$4.16 in Q1 2026, -$0.16 in Q4 2025, and -$46.58 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Citius Oncology | 58.02 Mn | 58.02 Mn | 1.34 Mn | -4.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.16 |
| Dec 31, 2025 | -0.16 |
| Sep 30, 2025 | -46.58 |
| Jun 30, 2025 | -0.11 |
| Mar 31, 2025 | -246.03 |
| Dec 31, 2024 | -13.61 |
| Jun 30, 2024 | -152.62 |
| Mar 31, 2024 | -4.42 |
| Dec 31, 2023 | -149.93 |
| Sep 30, 2023 | -0.19 |